Affimed Investor Event Highlighting AFM13 Clinical Development at the 64th American Society of Hematology (ASH) Annual Meeting
December 10, 2022, 4:00 p.m. CST / 5:00 p.m. EDT / 23:00 CET
View our collection of archived webcasts.
December 10, 2022, 4:00 p.m. CST / 5:00 p.m. EDT / 23:00 CET
November 15, 2022, 8:30 a.m. EST / 14:30 CET
November 3, 2022, 10:30 a.m. EDT / 7:30 a.m. PDT / 15:30 CET
November 16, 2022, 12:55 p.m. GMT / 7:55 a.m. EST / 13:55 CET
See how Affimed is putting our proven track record of innovation into practice.
View our corporate presentation
See the presentation of the updated clinical data from the phase 1/2 study of AFM13 precomplexed with cord-blood derived NK cells at AACR 2022